Ledger.Open graph →
SEC Form D · filed August 24, 2021

Immunitas Therapeutics, Inc

Offering
$57.7M
Sold
$29.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WALTHAM, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Laura Brass · Waltham, MADirectorDan Matloff · Waltham, MAExecJeffrey Goldberg · FRANKLIN, TNExec · DirectorAmanda Wagner · Waltham, MAExecKai Wucherpfennig · Waltham, MADirectorJiaping Gu · Waltham, MADirectorJuergen Eckhardt · Philadelphia, PADirectorChristoph Westphal · Boston, MADirectorLucio Iannone · Boston, MADirectorLaura Brass · Waltham, MADirectorAmanda Wagner · Waltham, MAExecKai Wucherpfennig · Waltham, MADirectorDan Matloff · Waltham, MAExecJiaping Gu · Waltham, MADirectorJeffrey Goldberg · NEW YORK, NYExec · DirectorJuergen Eckhardt · Philadelphia, PADirectorChristoph Westphal · Boston, MADirectorLucio Iannone · Branford, CTDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗